HAL Allergy Group, one of Europe's leading specialists in allergen immunotherapy, has researched and produced allergen extracts for therapeutic and diagnostic purposes—like treating house mite, pet, or grass allergies—for decades. With state-of-the-art production facilities in Leiden, Netherlands, for manufacturing products and Contract Manufacturing Organisation (CMO) orders, including recent COVID-19 vaccines, the company upgraded its Enterprise Asset Management (EAM) system from fragmented programs. IFS simplified maintenance operations, streamlining daily asset management, boosting efficiency, and ensuring reliable production across facilities.

Join for free to read